RecruitingNot Applicable

Clinical Study of a Novel Sliding Compression Locking Plate in the Treatment of Fresh Femoral Neck Fractures

China1,150 participantsStarted 2024-12-10

Plain-language summary

To verify the safety and efficacy of sliding compression locking plates in the treatment of fresh femoral neck fractures

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Age \>=18 years old, gender is not limited;
✓. Patients diagnosed with femoral neck fracture;
✓. Patients with indications for internal fixation of femoral neck fracture and able to tolerate surgery;
✓. The subject or his legal representative is informed of the nature of the study and agrees to participate in the study.

✕. Participants who had participated in clinical studies of other drugs, biologics or medical devices before enrollment and did not reach the primary study endpoint time limit;
✕. The patient is known to have a history of allergy to one or more implanted materials;
✕. Patients determined by researchers to be physically weak or unable to tolerate surgery due to other systemic diseases;
✕. Active infection of the hip joint or other parts of the body is determined by the investigator;
✕. Diagnosed as metabolic bone disease, radiation bone disease, etc.;
✕. Severe hip contracture deformity or severe muscle loss fused to the functional position for a long time without pain;
✕. have inflammatory arthritis, such as rheumatoid arthritis, systemic lupus erythematosus arthritis, ankylosing spondylitis, etc.;
✕. The patient is mentally incapable or unable to understand the requirements of participating in the study, and it is difficult to cooperate;

Femoral neck shortened

Timeframe: 1 year

NCT IDNCT06713291

SponsorChinese PLA General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10-31

Wei Zhang

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Age \>=18 years old, gender is not limited;
✓. Patients diagnosed with femoral neck fracture;
✓. Patients with indications for internal fixation of femoral neck fracture and able to tolerate surgery;
✓. The subject or his legal representative is informed of the nature of the study and agrees to participate in the study.

✕. Participants who had participated in clinical studies of other drugs, biologics or medical devices before enrollment and did not reach the primary study endpoint time limit;
✕. The patient is known to have a history of allergy to one or more implanted materials;
✕. Patients determined by researchers to be physically weak or unable to tolerate surgery due to other systemic diseases;
✕. Active infection of the hip joint or other parts of the body is determined by the investigator;
✕. Diagnosed as metabolic bone disease, radiation bone disease, etc.;
✕. Severe hip contracture deformity or severe muscle loss fused to the functional position for a long time without pain;
✕. have inflammatory arthritis, such as rheumatoid arthritis, systemic lupus erythematosus arthritis, ankylosing spondylitis, etc.;
✕. The patient is mentally incapable or unable to understand the requirements of participating in the study, and it is difficult to cooperate;